Page last updated: 2024-10-21

4-iodo-2,5-dimethoxyphenylisopropylamine and Epilepsy, Absence

4-iodo-2,5-dimethoxyphenylisopropylamine has been researched along with Epilepsy, Absence in 1 studies

4-iodo-2,5-dimethoxyphenylisopropylamine: RN given refers to unlabeled parent cpd without isomeric designation; a serotonin agonist
2-(4-iodo-2,5-dimethoxyphenyl)-1-methylethylamine : An organoiodine compound that is amphetamine bearing two methoxy substituents at positions 2 and 5 as well as an iodo substituent at position 4.

Epilepsy, Absence: A seizure disorder usually occurring in childhood characterized by rhythmic electrical brain discharges of generalized onset. Clinical features include a sudden cessation of ongoing activity usually without loss of postural tone. Rhythmic blinking of the eyelids or lip smacking frequently accompanies the SEIZURES. The usual duration is 5-10 seconds, and multiple episodes may occur daily. Juvenile absence epilepsy is characterized by the juvenile onset of absence seizures and an increased incidence of myoclonus and tonic-clonic seizures. (Menkes, Textbook of Child Neurology, 5th ed, p736)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bercovici, E1
Cortez, MA1
Snead, OC1

Other Studies

1 other study available for 4-iodo-2,5-dimethoxyphenylisopropylamine and Epilepsy, Absence

ArticleYear
5-HT2 modulation of AY-9944 induced atypical absence seizures.
    Neuroscience letters, 2007, May-11, Volume: 418, Issue:1

    Topics: Amphetamines; Animals; Anticholesteremic Agents; Epilepsy, Absence; Ketanserin; Piperazines; Rats; R

2007